Skip to main content

Table 3 Immunosuppression regimens received during the course of the study and related BMI changes

From: Weight change trajectories in Aboriginal and Torres Strait islander Australians after kidney transplantation: a cohort analysis using the Australia and New Zealand Dialysis and Transplant registry (ANZDATA)

Immunosuppression regimens

Number (Percent)

Mean BMI (kg/m2)

@Tx

3 M

6 M

12 M

24 M

Azathioprine

734 (11%)

26.3

26.6

27.1

27.5

27.6

Cyclosporin A

3027 (46%)

26.3

26.6

27.1

27.5

27.6

Everolimus

84 (1%)

26.2

26.4

26.9

27.3

27.4

Mycophenolate Mofetil

4563 (70%)

26.3

26.5

27.0

27.4

27.6

Mycophenolate Sodium

1041 (16%)

26.7

27.0

27.5

27.8

28.0

Prednisolone

6527 (100%)

26.3

26.6

27.1

27.5

27.6

Sirolimus

246 (4%)

26.1

26.1

26.6

27.0

27.1

Tacrolimus

3530 (54%)

26.6

26.8

27.3

27.8

28.0

  1. Key: @tx; at the time of transplantation, 3 M; at 3 months post-transplantation, 6 M; at 6 months post-transplantation, 12 M; at 12 month post-transplantation, 24 M; at 24 months post-transplantation